We are live on
!
Find out more
TEE
Tibra Equities Europe Portfolio holdings
AUM
$90.4M
1-Year Est. Return
37.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.25%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
–
Cap. Flow
+$229M
Cap. Flow
% of AUM
98.37%
Top 10 Holdings %
Top 10 Hldgs %
50.19%
Holding
126
New
126
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$22.9M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$22.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$14.8M |
| 4 |
Dell
DELL
|
+$12.4M |
| 5 |
PPLI
People Inc
PPLI
|
+$11.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.17% |
| 2 | Communication Services | 9.76% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Materials | 7.51% |
| 5 | Industrials | 7.03% |
Similar funds
EM
BBHBI
EA
SCMU
DCM
BCIMC
LSC
RCM
Tibra Equities Europe's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Tibra Equities Europe, which disclosed 126 positions worth $233M. Its ten largest holdings account for 50% of the portfolio.
Its largest position is iShares Biotechnology ETF: 214,152 shares worth $22.9M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, followed by Communication Services and Consumer Discretionary.
- Tibra Equities Europe's largest Q4 2017 buy was iShares Biotechnology ETF: 214,152 shares worth $22.9M.
- Tibra Equities Europe's ten largest holdings make up 50% of its $233M portfolio in Q4 2017.
- Tibra Equities Europe disclosed 126 positions in Q4 2017, its first 13F filing on record.
Based on Tibra Equities Europe's 13F filing for Q4 2017, filed 9 Feb 2018.